Manhattan Associates(US:MANH)2025-10-21 20:02Revenue Performance - Consolidated total revenue for Q3 2025 was $275.8 million, a 3% increase from $266.7 million in Q3 2024[5] - For the nine months ended September 30, 2025, total revenue was $811.0 million, compared to $786.6 million for the same period in 2024[8] - The company expects total revenue for the full year 2025 to be in the range of $1,073 million to $1,077 million, reflecting a growth of 3%[9] - Total revenue for 2024 reached $1,042,352 thousand, with the Americas segment contributing $802,486 thousand, EMEA $190,523 thousand, and APAC $49,343 thousand[28] Earnings and Profitability - GAAP diluted earnings per share for Q3 2025 was $0.96, down from $1.03 in Q3 2024, while non-GAAP adjusted diluted EPS increased slightly to $1.36 from $1.35[2][7] - Adjusted diluted EPS guidance for 2025 is between $4.95 and $4.97, indicating a growth of 5%[9] - Adjusted diluted EPS (Non-GAAP) for Q3 2025 was $1.36, slightly up from $1.35 in Q3 2024[21] - GAAP diluted EPS for 2024 was $3.51, with adjusted diluted EPS at $4.72, reflecting a strong performance across the quarters[28] Operating Income - Operating income for Q3 2025 was $75,828, compared to $75,090 in Q3 2024, reflecting a year-over-year increase of 1%[21] - Adjusted operating income for the nine months ended September 30, 2025, was $295.7 million, up from $271.5 million in 2024[8] - GAAP operating income for 2024 was $261,596 thousand, with adjusted non-GAAP operating income at $361,804 thousand, indicating effective cost management[28] Cash Flow and Investments - Cash flow from operations for Q3 2025 was $93.1 million, significantly up from $62.3 million in Q3 2024[7] - Net cash provided by operating activities for the nine months ended September 30, 2025, was $242,420, up from $190,299 in 2024, marking a 27.4% increase[27] - The company repurchased 233,425 shares for a total investment of $49.9 million during Q3 2025, with an additional $100 million share repurchase authority replenished in October 2025[7][9] - The company repurchased $238,187 in common stock during the nine months ended September 30, 2025[27] Expenses - Research and development expenses increased to $6,216 in Q3 2025 from $5,117 in Q3 2024, representing a 21.5% increase[22] - Capital expenditures for 2024 totaled $8,675 thousand, with $3,128 thousand spent in Q4 alone[31] Assets and Liabilities - Total current assets as of September 30, 2025, were $525,770, an increase from $503,264 at the end of 2024[25] - Total liabilities as of September 30, 2025, were $459,904, compared to $458,121 at the end of 2024, indicating a slight increase[25] Foreign Exchange Impact - The company reported a total of $1,369 thousand in revenue impact from currency fluctuations for 2024, with operating income impact of $1,882 thousand[29] - The company experienced a total impact of $2,827 thousand from changes in the Indian Rupee exchange rate in 2024, highlighting the significance of foreign operations[29] Future Revenue Visibility - Remaining performance obligations (RPO) as of September 30, 2024, were $1,686,421 thousand, indicating strong future revenue visibility[33]